PT  - JOURNAL ARTICLE
AU  - Cecconello, M. S.
AU  - Diniz, G. L.
AU  - Silva, E. B.
TI  - Using the infection fatality rate to predict the evolution of Covid-19 in Brazil
AID  - 10.1101/2020.07.01.20144279
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.01.20144279
4099  - http://medrxiv.org/content/early/2020/07/02/2020.07.01.20144279.short
4100  - http://medrxiv.org/content/early/2020/07/02/2020.07.01.20144279.full
AB  - In this work we are going to use estimates of Infection Fatality Rate (IFR) for Covid-19 in order to predict the evolution of Covid-19 in Brazil. To this aim, we are going to fit the parameters of the SIR model using the official deceased data available by governmental agencies. Furthermore, we are going to analyse the impact of social distancing policies on the transmission parameters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has no funding support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was conducted using only data publicly available such that individual subjects cannot be identified in any way.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the manuscript are public available. https://covid.saude.gov.br